Spark Investment Management’s Audentes Therapeutics, Inc BOLD Stock Holding History

Spark Investment Management’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-71,534	Closed	-$4.28M	–	595
2019 Q4	$4.28M	Sell	71,534 -156,760	-69%	-$5.88M	0.5%	46
2019 Q3	$6.41M	Sell	228,294 -32,106	-12%	-$1.1M	0.82%	22
2019 Q2	$9.86M	Buy	260,400 +17,700	+7%	+$680K	0.68%	31
2019 Q1	$9.47M	Buy	242,700 +153,500	+172%	+$4.4M	0.44%	61
2018 Q4	$1.9M	Buy	89,200 +59,000	+195%	+$1.52M	0.13%	211
2018 Q3	$1.2M	Sell	30,200 -92,300	-75%	-$3.44M	0.07%	357
2018 Q2	$4.68M	Sell	122,500 -69,700	-36%	-$2.58M	0.27%	117
2018 Q1	$5.78M	Buy	192,200 +97,900	+104%	+$3.31M	0.37%	77
2017 Q4	$2.95M	Buy	94,300 +14,100	+18%	+$387K	0.16%	194
2017 Q3	$2.25M	Buy	+80,200	New	+$1.74M	0.12%	244
2017 Q2	–	Sell	-27,700	Closed	-$472K	–	918
2017 Q1	$472K	Buy	+27,700	New	+$448K	0.03%	551

Spark Investment Management's BOLD Position: Q1 2020 in Review

Spark Investment Management sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 71,534 shares — an estimated $4.28M sold.

Spark Investment Management first reported a position in BOLD in Q1 2017 and held it in 11 quarters. The position peaked at $9.86M in Q2 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

Spark Investment Management reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
Spark Investment Management sold 71,534 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $4.28M.
Spark Investment Management first reported a position in Audentes Therapeutics, Inc in Q1 2017 and held it in 11 quarters.
Spark Investment Management's Audentes Therapeutics, Inc position peaked at $9.86M in Q2 2019.
0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Spark Investment Management's 13F filing for Q1 2020, filed 12 May 2020.